Summary: Dr. Jamison will present his take on relevant preclinical models at the 4th Annual Dry AMD Therapeutic Development Summit
Content
Experimentica’s Chief Development Officer Dr. Jeff Jamison will present his take on relevant preclinical models at the 4th Annual Dry AMD Therapeutic Development Summit in Boston, MA on November 15, 2023.
Specifically, Dr. Jamison will:
- Compare differences between commonly used models of dry AMD in innovative drug development
- Highlight Experimentica’s recently validated laser-induced Geographic Atrophy model
The conference unites the industry leaders at the forefront of developing and delivering innovative treatments against dry AMD, with an unparalleled quality of technical insights on preclinical and clinical ocular drug development.
Experimentica is proud to sponsor this year’s edition of the conference.